Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa

Andrew P South^{1

2

3}

Affiliations

¹ Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
² Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
³ Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Editorial

Andrew P South. Br J Dermatol. 2024.

. 2024 Sep 18;191(4):482-483.

doi: 10.1093/bjd/ljae300.

Andrew P South^{1

2

3}

¹ Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
² Department of Otolaryngology - Head and Neck Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
³ Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

No abstract available

Conflict of interest statement

Conflicts of interest The author declares no conflicts of interest.

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
Primerano A, De Domenico E, Cianfarani F, De Luca N, Floriddia G, Teson M, Cristofoletti C, Cardarelli S, Scaglione GL, Baldini E, Cangelosi D, Uva P, Reinoso Sánchez JF, Roubaty C, Dengjel J, Nyström A, Mastroeni S, Ulisse S, Castiglia D, Odorisio T. Primerano A, et al. Br J Dermatol. 2024 Sep 18;191(4):568-579. doi: 10.1093/bjd/ljae225. Br J Dermatol. 2024. PMID: 38820176